Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Broxaterol

From Wikipedia, the free encyclopedia
Broxaterol
Kekulé skeletal formula of broxaterol
Kekulé skeletal formula of broxaterol
Names
IUPAC name
1-(3-Bromo-5-isoxazolyl)-2-(tert-butylamino)ethanol
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
ECHA InfoCard100.071.338Edit this at Wikidata
MeSHBroxaterol
UNII
  • InChI=1S/C9H15BrN2O2/c1-9(2,3)11-5-6(13)7-4-8(10)12-14-7/h4,6,11,13H,5H2,1-3H3 checkY
    Key: JBRBWHCVRGURBA-UHFFFAOYSA-N checkY
  • InChI=1/C9H15BrN2O2/c1-9(2,3)11-5-6(13)7-4-8(10)12-14-7/h4,6,11,13H,5H2,1-3H3
    Key: JBRBWHCVRGURBA-UHFFFAOYAK
  • CC(C)(C)NCC(C1=CC(=NO1)Br)O
Properties
C9H15BrN2O2
Molar mass263.135 g·mol−1
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
Chemical compound

Broxaterol is aβ2 adrenoreceptor agonist.[1] It is part of a class ofdrugs that affect thesmooth muscle receptors in the body, often in use cases forrespiratory disease that respond to this type of treatment.

Synthesis

[edit]

The1,3-dipolar cycloaddition between bromonitrile oxide, producedin situ from dibromoformaldoxime, and 3-butyn-2-one gives a mixture of isoxazoles, mainly theisomer shown required for broxaterol. Selective α-bromination of the acetyl group withpyridinium tribromide gives a bromoketone whosecarbonyl group is reduced withsodium borohydride to produce a bromoethanol derivative. Treatment of this withtert-butylamine yields broxaterol.[2][3][4][5]

References

[edit]
  1. ^Nava S, Crotti P, Gurrieri G, Fracchia C, Rampulla C (January 1992)."Effect of a beta 2-agonist (broxaterol) on respiratory muscle strength and endurance in patients with COPD with irreversible airway obstruction".Chest.101 (1):133–40.doi:10.1378/chest.101.1.133.PMID 1345900. Archived fromthe original on 2013-04-14.
  2. ^US patent 4276299, Davide Della Bella and Dario Chiarino, "1-(3-Bromo-isoxazol-5-yl)-2-tert.butylaminoethanol", issued 1981-06-30, assigned to Zambon SpA 
  3. ^De Amici, Marco; De Micheli, Carlo; Carrea, Giacomo; Spezia, Sandro (1989). "Chemoenzymatic synthesis of chiral isoxazole derivatives".The Journal of Organic Chemistry.54 (11):2646–2650.doi:10.1021/jo00272a037.
  4. ^Rohloff, John C.; Robinson, James; Gardner, John O. (1992). "Bromonitrile oxide [3+2] cycloadditions in water".Tetrahedron Letters.33 (22):3113–3116.doi:10.1016/S0040-4039(00)79827-3.
  5. ^Battilocchio, Claudio; Bosica, Francesco; Rowe, Sam M.; et al. (2017)."Continuous Preparation and Use of Dibromoformaldoxime as a Reactive Intermediate for the Synthesis of 3-Bromoisoxazolines".Organic Process Research & Development.21 (10):1588–1594.doi:10.1021/acs.oprd.7b00229.
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists


Stub icon

Thisdrug article relating to therespiratory system is astub. You can help Wikipedia byadding missing information.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Broxaterol&oldid=1292450190"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp